Authors: GOULET M MORISSETTE M CALON F BLANCHET PJ FALARDEAU P BEDARD PJ DIPAOLO T

Citation: M. Goulet et al., CONTINUOUS OR PULSATILE CHRONIC D-2 DOPAMINE-RECEPTOR AGONIST (U91356A) TREATMENT OF DRUG-NAIVE 4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MONKEYSDIFFERENTIALLY REGULATES BRAIN D-1 AND D-2 RECEPTOR EXPRESSION - IN-SITU HYBRIDIZATION HISTOCHEMICAL ANALYSIS, Neuroscience, 79(2), 1997, pp. 497-507

Authors: MORISSETTE M GOULET M SOGHOMONIAN JJ BLANCHET PJ CALON F BEDARD PJ DIPAOLO T

Citation: M. Morissette et al., PREPROENKEPHALIN MESSENGER-RNA EXPRESSION IN THE CAUDATE-PUTAMEN OF MPTP MONKEYS AFTER CHRONIC TREATMENT WITH THE D-2 AGONIST U91356A IN CONTINUOUS OR INTERMITTENT MODE OF ADMINISTRATION - COMPARISON WITH L-DOPA THERAPY, Molecular brain research, 49(1-2), 1997, pp. 55-62

Authors: MORISSETTE M GOULET M CALON F FALARDEAU P BLANCHET PJ BEDARD PJ DIPAOLO T

Citation: M. Morissette et al., CHANGES OF D-1 AND D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IN THE BRAINS OF MONKEYS LESIONED WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRECTION WITH CHRONIC ADMINISTRATION OF L-3,4-DIHYDROXYPHENYLALANINE, Molecular pharmacology, 50(5), 1996, pp. 1073-1079

Authors: BLANCHET PJ CALON F MARTEL JC BEDARD PJ DIPAOLO T WALTERS RR PIERCEY MF

Citation: Pj. Blanchet et al., CONTINUOUS ADMINISTRATION DECREASES AND PULSATILE ADMINISTRATION INCREASES BEHAVIORAL SENSITIVITY TO A NOVEL DOPAMINE D-2 AGONIST (U-91356A) IN MPTP-EXPOSED MONKEYS, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 854-859

Authors: CALON F GOULET M BLANCHET PJ MARTEL JC PIERCEY MF BEDARD PJ DIPAOLO T

Citation: F. Calon et al., LEVODOPA OR D2 AGONIST-INDUCED DYSKINESIA IN MPTP MONKEYS - CORRELATION WITH CHANGES IN DOPAMINE AND GABA(A) RECEPTORS IN THE STRIATOPALLIDAL COMPLEX, Brain research, 680(1-2), 1995, pp. 43-52